| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | 0.092 | 0.6 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |